ABC | Volume 111, Nº1, Julho 2018

Artigo Especial Ayub-Ferreira Diretriz de ACM da SBC Arq Bras Cardiol. 2018; 111(1):4-12 1. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Third INTERMACS Annual Report: the evolution of destination therapy in the United States. J Heart Lung Transplant. 2011;30(2):115-23. 2. MoskowitzAJ,RoseEA,GelijnsAC.Thecostof long-termLVAD implantation. Ann Thorac Surg. 2001;71(3 Suppl):S195-8. 3. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435-43. 4. Reedy JE, Swartz MT, Termuhlen DF, Pennington DG, McBride LR, Miller LW, et al. Bridge to heart transplantation: importance of patient selection. J Heart Transplant. 1990;9(5):473-80. 5. Lietz K, Miller LW. Patient selection for left-ventricular assist devices. Curr Opin Cardiol. 2009;24(3):246-51. 6. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116(5):497-505. 7. Cowger J, Sundareswaran K, Rogers JG, Park SJ, Pagani FD, Bhat G, et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J AmColl Cardiol. 2013;61(3):313-21. 8. Oz MC, Goldstein DJ, Pepino P, Weinberg AD, Thompson SM, Catanese KA, et al. Screening scale predicts patients successfully receiving long- term implantable left ventricular assist devices. Circulation. 1995;92(9 Suppl):II169-73. 9. Deng MC, Loebe M, El-Banayosy A, Gronda E, Jansen PG, Vigano M, et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation. 2001;103(2):231-7. 10. SantamoreWP, Gray LA Jr. Left ventricular contributions to right ventricular systolic function during LVAD support. Ann Thorac Surg. 1996;61(1):350-6. 11. Loforte A, Stepanenko A, Potapov EV, Musumeci F, Dranishnikov N, Schweiger M, et al. Temporary right ventricular mechanical support in high- risk left ventricular assist device recipients versus permanent biventricular or total artificial heart support. Artif Organs. 2013;37(6):523-30. 12. Scalia GM, McCarthy PM, Savage RM, Smedira NG, Thomas JD. Clinical utility of echocardiography in the management of implantable ventricular assist devices. J Am Soc Echocardiogr. 2000;13(8):754-63. 13. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233-70. 14. Rudski LG, LaiWW, Afilalo J, Hua L, HandschumacherMD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685-713. 15. Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, et al; International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanicalcirculatorysupport:executivesummary. JHeartLungTransplant. 2013;32(2):157-87. 16. Argiriou M, Kolokotron SM, Sakellaridis T, Argiriou O, Charitos C, Zarogoulidis P, et al. Right heart failure post left ventricular assist device implantation. J Thorac Dis. 2014 Mar;6 Suppl 1:S52-9. 17. Matthews JC, Koelling TM, Pagani FD, Aaronson KD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51(22):2163-72. 18. Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al; HeartMate II Clinical Investigators. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139(5):1316-24. 19. Fitzpatrick JR 3 rd , Frederick JR, Hsu VM, Kozin ED, O’Hara ML, Howell E, et al. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008;27(12):1286-92. 20. Atluri P, Goldstone AB, Fairman AS, MacArthur JW, Shudo Y, Cohen JE, et al. Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era. Ann Thorac Surg. 2013;96(3):857-63. 21. Holman WL, Acharya D, Siric F, Loyaga-Rendon RY. Assessment and management of right ventricular failure in left ventricular assist device patients. Circ J. 2015;79(3):478-86. 22. Goldstein D, Neragi-Miandoab S. Mechanical bridge to decision: what are the options for themanagement of acute refractory cardiogenic shock? Curr Heart Fail Rep. 2011;8(1):51-8. 23. Kar B, Basra SS, Shah NR, Loyalka P. Percutaneous circulatory support in cardiogenic shock: interventional bridge to recovery. Circulation. 2012;125(14):1809-17. 24. Gilotra NA, Stevens GR. Temporary mechanical circulatory support: a reviewof the options, indications, and outcomes. ClinMed Insights Cardiol. 2014;8(Suppl 1):75-85. 25. ThieleH, Lauer B, Hambrecht R, Boudriot E, CohenHA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation. 2001;104(24):2917-22. 26. RaessDH,WeberDM.Impella2.5.JCardiovascTranslRes.2009;2(2):168-72. 27. Rihal CS, Naidu SS, GivertzMM, SzetoWY, Burke JA, Kapur NK, et al. Society for Cardiovascular Angiography and Interventions (SCAI); Heart Failure Society of America (HFSA); Society of Thoracic Surgeons (STS); American Heart Association (AHA), and American College of Cardiology (ACC). 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care:EndorsedbytheAmericanHeartAssociation,theCardiologicalSociety of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention. J Am Coll Cardiol. 2015;65(19):e7-e26. 28. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015;34(12):1495-504. 29. Patlolla B, Beygui R, Haddad F. Right-ventricular failure following left ventricle assist device implantation. Curr Opin Cardiol. 2013;28(2):223-33. 30. Meineri M, Van Rensburg AE, Vegas A. Right ventricular failure after LVAD implantation: prevention and treatment. Best Pract Res Clin Anaesthesiol. 2012;26(2):217-29. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 12